Lv1
100 积分 2024-06-29 加入
The gut microbiota and cardiovascular disease: Exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics
5天前
已完结
Microbiota-derived metabolites and cardiovascular implications in Inflammatory Bowel Disease (IBD)
10天前
已完结
The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Microbiome Interactions and Therapeutic Targets
21天前
已完结
Aging‐Dependent Hepatic YAP1 Reduction Promotes Metabolic Dysfunction‐Associated Steatotic Liver Disease via Gut Microbiota Dysbiosis With Akkermansia muciniphila Downregulation
21天前
已完结
Aging‐Dependent Hepatic YAP1 Reduction Promotes Metabolic Dysfunction‐Associated Steatotic Liver Disease via Gut Microbiota Dysbiosis With Akkermansia muciniphila Downregulation
26天前
已完结
Type 3c Diabetes Mellitus: Epidemiology, Diagnosis, Management, and Research Imperatives With Insights From the United Arab Emirates and Global Contexts
1个月前
已完结
Mechanosensing by Piezo1 and its implications for physiology and various pathologies
1个月前
已完结
Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier
2个月前
已完结
Electroacupuncture attenuates intestinal epithelial ferroptosis in inflammatory bowel disease via Piezo1-mediated mitochondrial homeostasis
2个月前
已完结
Butyrate Inhibits the HDAC8/NF-κB Pathway to Enhance Slc26a3 Expression and Improve the Intestinal Epithelial Barrier to Relieve Colitis
2个月前
已完结
皖公网安备34019202002308
